Making them pay is important but it’s not going to stop drugmakers from endangering public health.
On the horizon: A new omicron-focused version of the Moderna vaccine that may offer longer protection and a stronger immune response.
After battling drug manufacturers and distributors in court for years, local and state governments are about to receive a windfall that could expand access to treatments that can save lives.
As boosters are authorized for all three COVID-19 shots available in the US, the ability to swap out vaccine types looks to be a boon to the immune system.
Your body produces antibodies after an infection or vaccine, but these slowly decline over time. New Johnson & Johnson data sheds light on the duration of protection and the need for booster shots.
Dan Barouch, Harvard Medical School professor and head of Beth Israel Deaconess’ Center for Virology and Vaccine Research, was awarded Harvard’s George Ledlie Prize for work that culminated in one of three vaccines against COVID-19 approved for use in the U.S.
As many teens and adults in the US restart their social lives, parents of children under the age of 12 wonder when their kids will also be able to experience the freedom that comes with vaccination.
COVID-19 has exacerbated a backlog of domestic and foreign drug manufacturing inspections that the FDA is still too short-staffed to adequately deal with.
The CDC first paused, then unpaused, the administration of the Johnson & Johnson COVID-19 vaccine due to concerns about blood clots. But what are those clots, and how do they form?
Vaccine manufacturing is complex, with lots of potential points for errors. But it also has extensive quality control checks and approvals.
/
2
